AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect

AstraZeneca (AZN) will report first-quarter 2024 results on Apr 25, before market open. In the last reported quarter, the company missed earnings expectations by 1.35%.Factors to NoteSales of AstraZeneca’s key medicines, mainly cancer drugs — Lynparza, Tagrisso and Imfinzi — and diabetes medicine Farxiga, are expected to have driven the company’s top line in the first quarter, backed by strong demand trends. Price reductions of some drugs in emerging markets hurt product sales in the fourth quarter, a trend ...